Rafael Carrión

530 total citations
20 papers, 371 citations indexed

About

Rafael Carrión is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rafael Carrión has authored 20 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rafael Carrión's work include Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Rafael Carrión is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Rafael Carrión collaborates with scholars based in Spain, United States and Argentina. Rafael Carrión's co-authors include Javier Menárguez, Carmen Rivas, Carlos Montalbán, José L. Díez‐Martín, Manuel Serrano, Miguel Á. Piris, David Serrano, Víctor Abraira, Ismael Buño and J García Laraña and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Rafael Carrión

18 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Carrión Spain 9 238 165 91 86 68 20 371
J. Lim United Kingdom 9 192 0.8× 122 0.7× 53 0.6× 35 0.4× 112 1.6× 13 340
Teresio Motta Italy 8 244 1.0× 283 1.7× 47 0.5× 52 0.6× 28 0.4× 11 394
David Straus United States 6 467 2.0× 280 1.7× 123 1.4× 61 0.7× 40 0.6× 8 536
Francesco Volzone Italy 8 140 0.6× 98 0.6× 25 0.3× 62 0.7× 60 0.9× 17 260
Donna M. Weber United States 4 110 0.5× 126 0.8× 72 0.8× 99 1.2× 249 3.7× 4 381
Fergus Jack United Kingdom 6 265 1.1× 158 1.0× 47 0.5× 37 0.4× 17 0.3× 10 347
Athena Kritharis United States 10 84 0.4× 78 0.5× 120 1.3× 45 0.5× 48 0.7× 19 381
Motohiko Aiba Japan 10 81 0.3× 71 0.4× 105 1.2× 95 1.1× 17 0.3× 19 311
Elizabeth L. Courville United States 11 108 0.5× 147 0.9× 25 0.3× 51 0.6× 136 2.0× 46 376
M Ostronoff France 11 144 0.6× 123 0.7× 42 0.5× 125 1.5× 77 1.1× 26 389

Countries citing papers authored by Rafael Carrión

Since Specialization
Citations

This map shows the geographic impact of Rafael Carrión's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Carrión with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Carrión more than expected).

Fields of papers citing papers by Rafael Carrión

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Carrión. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Carrión. The network helps show where Rafael Carrión may publish in the future.

Co-authorship network of co-authors of Rafael Carrión

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Carrión. A scholar is included among the top collaborators of Rafael Carrión based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Carrión. Rafael Carrión is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carrión, Rafael, et al.. (2025). Pleural Effusion Secondary to Multiple Myeloma: A Rare Presentation. Open Respiratory Archives. 7(2). 100422–100422.
3.
Jiménez‐Fonseca, Paula, Caterina Calderón, Alberto Carmona‐Bayonas, et al.. (2018). The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables. Clinical & Translational Oncology. 20(11). 1392–1399. 11 indexed citations
4.
Cabezón‐Gutiérrez, Luis, et al.. (2012). ALK-Mutated Non-Small-Cell Lung Cancer: A New Strategy for Cancer Treatment. Lung. 190(4). 381–388. 7 indexed citations
5.
Serrano, David, Rafael Carrión, Pilar Miralles, et al.. (2008). Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with High Risk Hematologic Malignancies. Blood. 112(11). 4387–4387. 1 indexed citations
6.
Alegre, Adrían, Beatriz Aguado, Juan José Lahuerta, et al.. (2007). Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias.. Blood. 110(11). 2726–2726. 1 indexed citations
7.
8.
Serrano, David, Pascual Balsalobre, Rafael Carrión, et al.. (2006). Comparative Study of Autologous Stem Cell Transplant (ASCT) in HIV-1 Positive (HIV+) on Haart and HIV-1 Negative (HIV−) Non Hodgkin Lymphoma (NHL) Patients.. Blood. 108(11). 3063–3063. 4 indexed citations
9.
Serrano, David, Rafael Carrión, Pascual Balsalobre, et al.. (2005). HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Experimental Hematology. 33(4). 487–494. 52 indexed citations
10.
Buño, Ismael, Milagros González‐Rivera, Javier López Jiménez, et al.. (2005). A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.. PubMed. 90(10). 1373–9. 37 indexed citations
11.
Díez‐Martín, José L., et al.. (2004). Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect. Bone Marrow Transplantation. 33(10). 1037–1041. 5 indexed citations
12.
13.
Buño, Ismael, Pascual Balsalobre, A. Balas, et al.. (2003). Lineage-specific Chimaerism Quantification after T-cell Depleted Peripheral Blood Stem Cell Transplantation. Leukemia & lymphoma. 44(4). 659–667. 9 indexed citations
14.
Cristóbal, Eva, Juan C. Tardío, Rafael Carrión, et al.. (2000). Analysis of the Cyclin D1/p16/pRb Pathway in Parathyroid Adenomas. Endocrine Pathology. 11(3). 259–266. 4 indexed citations
15.
Cristóbal, Eva, Juan C. Tardío, José R. Polo, et al.. (2000). p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21<sup>WAF-1</sup> and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas. Endocrine Pathology. 11(3). 251–258. 7 indexed citations
16.
Menárguez, Javier, Marián Goicoechea, Eva Cristóbal, et al.. (1999). Lack of Relationship Between BsmI Vitamin D Receptor Polymorphism and Primary Hyperparathyroidism in a Spanish Female Population. Calcified Tissue International. 65(3). 214–216. 6 indexed citations
17.
Montalbán, Carlos, J. M. Castrillo, Gonzalo López‐Abente, et al.. (1999). Other Cancers in Patients with Gastric Malt Lymphoma. Leukemia & lymphoma. 33(1-2). 161–168. 30 indexed citations
18.
Arranz, R., Pilar García‐Alfonso, Paz Sobrino‐Vegas, et al.. (1998). Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.. Journal of Clinical Oncology. 16(4). 1538–1546. 47 indexed citations
19.
Castrillo, J. M., Carlos Montalbán, Víctor Abraira, et al.. (1996). Evaluation of the International Index in the Prognosis of High Grade Gastric Malt Lymphoma. Leukemia & lymphoma. 24(1-2). 159–163. 10 indexed citations
20.
Montalbán, Carlos, Víctor Abraira, Manuel Serrano, et al.. (1995). Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Annals of Oncology. 6(4). 355–362. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Lim Breakdown of academic impact, for papers by Teresio Motta Breakdown of academic impact, for papers by David Straus Breakdown of academic impact, for papers by Francesco Volzone Breakdown of academic impact, for papers by Donna M. Weber Breakdown of academic impact, for papers by Fergus Jack Breakdown of academic impact, for papers by Athena Kritharis Breakdown of academic impact, for papers by Motohiko Aiba Breakdown of academic impact, for papers by Elizabeth L. Courville Breakdown of academic impact, for papers by M Ostronoff
Rankless by CCL
2026